Kaspar Rufibach

发表

Comparison of design strategies for a three‐arm clinical trial with time‐to‐event endpoint: Power, time‐to‐analysis, and operational aspects

Elina Asikanius, Kaspar Rufibach, Jasmin Bahlo, 2016, Biometrical journal. Biometrische Zeitschrift.

Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug development

Markus Abt, Kaspar Rufibach, Hans Ulrich Burger, 2016, Pharmaceutical statistics.

Sequentially updating the likelihood of success of a Phase 3 pivotal time-to-event trial based on interim analyses or external information

Markus Abt, Kaspar Rufibach, Paul Jordan, 2016, Journal of biopharmaceutical statistics.

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?

Philip Griffiths, Kim Cocks, Kaspar Rufibach, 2020, Journal of Patient-Reported Outcomes.

Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond

Kaspar Rufibach, K. Rufibach, 2017, Pharmaceutical statistics.

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

Kim May Lee, Michael J. Grayling, Kevin Kunzmann, 2020, The American statistician.

Principal stratum strategy: Potential role in drug development.

Yi Liu, Heinz Schmidli, Satrajit Roychoudhury, 2021, Pharmaceutical statistics.

Estimands in hematologic oncology trials

Satrajit Roychoudhury, Kaspar Rufibach, Steven Sun, 2020, Pharmaceutical statistics.

Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: an exploratory outcomes analysis.

Daniel Taussky, Kaspar Rufibach, K. Rufibach, 2005, International journal of radiation oncology, biology, physics.

Limit distribution theory for maximum likelihood estimation of a log-concave density

Fadoua Balabdaoui, Jon A. Wellner, Kaspar Rufibach, 2009 .

Maximum likelihood estimation and confidence bands for a discrete log-concave distribution

Fadoua Balabdaoui, Kaspar Rufibach, Hanna Jankowski, 2011 .

Least Squares estimation of two ordered monotone regression curves

Filippo Santambrogio, Fadoua Balabdaoui, Kaspar Rufibach, 2009 .

Active Set and EM Algorithms for Log-Concave Densities Based on Complete and Censored Data

Kaspar Rufibach, Lutz Duembgen, L. Duembgen, 2007, 0707.4643.

Maximum-likelihood estimation of a log-concave density based on censored data

Dominic Schuhmacher, Kaspar Rufibach, Lutz Duembgen, 2013, 1311.6403.

Selection models with monotone weight functions in meta analysis

Kaspar Rufibach, K. Rufibach, 2011, Biometrical journal. Biometrische Zeitschrift.

The risk of early mortality of polytrauma patients associated to ISS, NISS, APACHE II values and prothrombin time

Kaspar Rufibach, K. Rufibach, M. Keel, 2013, Journal of trauma management & outcomes.

The Block Criterion for Multiscale Inference About a Density, With Applications to Other Multiscale Problems

Guenther Walther, Kaspar Rufibach, G. Walther, 2010 .

Comparison of different clinical development plans for confirmatory subpopulation selection.

Kaspar Rufibach, K. Rufibach, Meng Chen, 2016, Contemporary clinical trials.

Asymptotics of the discrete log‐concave maximum likelihood estimator and related applications

Fadoua Balabdaoui, Kaspar Rufibach, Marios Pavlides, 2011, 1107.3904.

Smooth tail-index estimation

Samuel Müller, Kaspar Rufibach, 2009 .